The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boritz, E.
Right arrow Articles by Wilson, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boritz, E.
Right arrow Articles by Wilson, C. C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*AIDS Medicines
The Journal of Immunology, 2003, 170: 1106-1116.
Copyright © 2003 by The American Association of Immunologists

Diverse Repertoire of HIV-1 p24-Specific, IFN-{gamma}-Producing CD4+ T Cell Clones Following Immune Reconstitution on Highly Active Antiretroviral Therapy1

Eli Boritz*, Brent E. Palmer{dagger}, Brian Livingston{ddagger}, Alessandro Sette{ddagger} and Cara C. Wilson2,*,{dagger}

Departments of * Immunology and {dagger} Medicine, University of Colorado Health Sciences Center, Denver, CO 80262; and {ddagger} Epimmune, San Diego, CA 92121

HIV-1 Ag-specific CD4+ T cell proliferative responses in human subjects with advanced, untreated HIV-1 disease are often weak or undetectable. Conversely, HIV-1-specific CD4+ T cell proliferation is occasionally detected following suppression of HIV-1 replication with highly active antiretroviral therapy (HAART). These observations suggest that unchecked HIV-1 replication may lead to depletion or dysfunction of HIV-1-specific CD4+ T cells, and that these defects may be partially corrected by viral suppression and subsequent immune reconstitution. However, the impact of this immune reconstitution on the repertoire of HIV-1-specific CD4+ T cells has not been thoroughly evaluated. To examine the HIV-1-specific CD4+ T cell repertoire in this clinical setting, we established HIV-1 p24-specific CD4+ T cell clones from a successfully HAART-treated subject whose pretreatment peripheral CD4 count was 0 cells/µl. Eleven different p24-specific CD4+ T cell clonotypes were distinguished among 13 clones obtained. Most clones produced both IFN-{gamma} and IL-4 upon Ag stimulation. Clones targeted eight distinct epitopes that varied in their conservancy among HIV-1 strains, and responses were restricted by one of three MHC II molecules. Clones showed a range of functional avidities for both protein and peptide Ags. Additional studies confirmed that multiple HIV-1 p24-derived epitopes were targeted by IFN-{gamma}-producing CD4+ cells from subjects first treated with HAART during advanced HIV-1 disease (median, 4.5 peptides/subject; range, 3–6). These results suggest that in HAART-treated subjects whose peripheral CD4+ T cell pools were once severely depleted, the HIV-1-specific CD4+ T cell repertoire may include a diverse array of clonotypes targeting multiple HIV-1 epitopes.




This article has been cited by other articles:


Home page
CVIHome page
C. C. Wilson, M. J. Newman, B. D. Livingston, S. MaWhinney, J. E. Forster, J. Scott, R. T. Schooley, and C. A. Benson
Clinical Phase 1 Testing of the Safety and Immunogenicity of an Epitope-Based DNA Vaccine in Human Immunodeficiency Virus Type 1-Infected Subjects Receiving Highly Active Antiretroviral Therapy
Clin. Vaccine Immunol., June 1, 2008; 15(6): 986 - 994.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. J. Miles, D. Elhassen, N. A. Borg, S. L. Silins, F. E. Tynan, J. M. Burrows, A. W. Purcell, L. Kjer-Nielsen, J. Rossjohn, S. R. Burrows, et al.
CTL Recognition of a Bulged Viral Peptide Involves Biased TCR Selection
J. Immunol., September 15, 2005; 175(6): 3826 - 3834.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. Boritz, B. E. Palmer, and C. C. Wilson
Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD4+ T Cells That Proliferate In Vitro Detected in Samples from Most Viremic Subjects and Inversely Associated with Plasma HIV-1 Levels
J. Virol., November 15, 2004; 78(22): 12638 - 12646.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Z. Zavala-Ruiz, I. Strug, B. D. Walker, P. J. Norris, and L. J. Stern
A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition
PNAS, September 7, 2004; 101(36): 13279 - 13284.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Pajot, V. Pancre, N. Fazilleau, M.-L. Michel, G. Angyalosi, D. M. Ojcius, C. Auriault, F. A. Lemonnier, and Y.-C. Lone
Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules
Int. Immunol., September 1, 2004; 16(9): 1275 - 1282.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. E. Kaufmann, P. M. Bailey, J. Sidney, B. Wagner, P. J. Norris, M. N. Johnston, L. A. Cosimi, M. M. Addo, M. Lichterfeld, M. Altfeld, et al.
Comprehensive Analysis of Human Immunodeficiency Virus Type 1-Specific CD4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides
J. Virol., May 1, 2004; 78(9): 4463 - 4477.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.